Long-term adverse event risks of oral JAK inhibitors versus immunomodulators: a literature review
Olivia Lamberg, Karan Pandher, Jonathon P. Troost, Henry W. Lim
Topics & Concepts
MedicineAdverse effectIncidence (geometry)TofacitinibJanus kinasePopulationMalignancyIntensive care medicineSkin cancerCohortInternal medicineCancerDermatologyRheumatoid arthritisOpticsEnvironmental healthCytokinePhysicsAutoimmune Bullous Skin DiseasesCutaneous lymphoproliferative disorders researchDermatology and Skin Diseases